The EU health regulator has approved the use of Pfizer’s COVID-19 pill. It is believed that this step will help in stopping the rising cases of corona and save the lives of high-risk patients.
Another weapon has been found in the fight against Coronavirus. The European Union’s health regulator has approved the use of American company Pfizer’s COVID-19 anti-viral pill (Pfizer’s COVID-19 Anti-Viral Pill). It is believed that this pill is also effective on new variants of corona and prevents the infection from spreading rapidly.
Such people will be used
The European Medicines Agency (EMA) has issued a statement saying that it has recommended authorization of Paxlovid for the treatment of adults suffering from corona who are at risk of becoming severe. Let us tell you that Paxlovid has so far been authorized for people 12 years of age and older in a handful of countries including the United States, Canada and Israel.
There are two types of tablets included
According to the news published in our affiliate website WION, quoted by the news agency AFP, the European Union has allowed member countries to use Pfizer’s pill as an emergency measure against Omicron before formal approval. The drug comprises two types of tablets, the first being COVID-19 therapy that can be taken at home. It is usually given to high-risk patients who require hospitalization due to deteriorating condition.
lowers the risk of death
It is taken twice a day for five days with another medicine called Ritonavir. Ritonavir is a generic antiviral. Unlike vaccines, it does not target the ever-evolving spike protein, which the corona virus uses to attack cells. A Pfizer study, which included more than 2,200 people at high risk of getting severe COVID-19, found that paxlovid reduced the risk of hospitalization or death by 89 percent.
